Degenerative joint disease (DJD) is the most common source of chronic pain in dogs, affecting an estimated 20% of the adult population, with welfare substantially improved by early recognition and multimodal pain management.
Degenerative joint disease is often called the hidden pain of companion animals because dogs are stoic by nature and owners frequently attribute signs to normal aging rather than treatable pain. The result is that many dogs live with chronic unmanaged pain for months or years before veterinary assessment. This represents a substantial welfare deficit that simple interventions can address. NSAIDs provide effective analgesia for most dogs with mild to moderate DJD and have excellent safety records when used with appropriate monitoring. Multimodal analgesia combining NSAIDs with gabapentin, environmental modification (ramps, orthopaedic beds, heated sleeping areas), and physiotherapy achieves better outcomes than single-agent therapy. Weight management deserves particular emphasis: adipose tissue is not metabolically inert but produces pro-inflammatory cytokines that worsen joint inflammation — dogs who lose excess weight show measurable improvement in mobility and lameness scores. Regular veterinary pain assessments using validated scales (CBPI, Liverpool) help track treatment effectiveness.